Long-term persistence with secukinumab in patients with moderate-to-severe psoriasis Joaquín Borrás-Blasco, Silvia Cornejo, Alejandro Valcuende-Rosique, Rebeca Alcala, Ana Navalon Bono

Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma Lorente Fernandez, Romero Dominguez, Asunción Albert Marí, Nunez Benito, Lopez Briz, Poveda Andres

Risk-sharing agreement based on health outcomes for the treatment of moderate–severe psoriasis with certolizumab pegol Andrés Navarro Ruiz, Fernando Toledo Alberola, Susana Aceituno